EFTA00635886.txt

"From: Paul Morris cj To: "jeffrey E." <jeevacationggmail.eom> Subject: fyi'm sure u know [C] Date: Mon, 10 Aug 2015"

"Editas Medicine is announcing a $120 million Series B round led by Bill Gates's chief advisor for science and technology, Boris Nikolic."

"CEO Katrine Bosley confirmed that Gates is one of the individuals investing in Editas alongside Nikolic."

"Nikolic... made the investment through what's been called "bng0," a new U.S.-based investment company... formed specifically to invest in Editas."

"CEO Katrine Bosley confirmed that Gates is one of the individuals investing in Editas"

"The list of financiers teaming with Nikolic reads like a rolodex... Among them: Deerfield Management"

"The list of financiers teaming with Nikolic... Among them: Viking Global Investors"

"The list of financiers teaming with Nikolic... Among them: Fidelity Management & Research"

"The list of financiers teaming with Nikolic... Among them: T. Rowe Price Associates"

"The list of financiers teaming with Nikolic... Among them: Google Ventures"

"The list of financiers teaming with Nikolic... Among them: Jennison Associates"

"The list of financiers teaming with Nikolic... Among them: Khosla Ventures"

"The list of financiers teaming with Nikolic... Among them: EcoR1 Capital"

"The list of financiers teaming with Nikolic... Among them: Casdin Capital"

"The list of financiers teaming with Nikolic... Among them: Omega Funds"

"The list of financiers teaming with Nikolic... Among them: Cowen Private Investments"

"The list of financiers teaming with Nikolic... Among them: Alexandria Venture Investments"

"Editas' founding VC backers—Flagship Ventures Polaris Partners and Third Rock Ventures-also pitched in"

"Editas' founding VC backers—Flagship Ventures Polaris Partners and Third Rock Ventures-also pitched in"

"Editas' founding VC backers—Flagship Ventures Polaris Partners and Third Rock Ventures-also pitched in"

"as did Partners Innovation Fund"

"the now-public cancer immunotherapy company Juno Therapeutics (NASDAQ: JUNO)—which Editas recently partnered with"

"CRISPR hauled in $64 million in April in a round that was led by Celgene"

"CRISPR hauled in $64 million in April in a round that was led by Celgene... and the venture arm of GlaxoSmithKline"

"Editas co-founder Keith Joung"

"the Broad's Feng Zhang (an Editas co-founder)"

"Doudna herself was an Editas co-founder"

"UC Berkeley's Jennifer Doudna"

"work led by the Broad's Feng Zhang"

"Paul Morris Managing Director Deutsche Bank Private Bank"

""We are on a marathon here at Editas," Bosley says"

"The work of Doudna's co-inventor Emmanuelle Charpentier is licensed to CRISPR"

"Doudna's work is licensed to Caribou"

"Caribou, which in turn has licensed use of its technology for human therapies to Intellia"